Journal of Pharmaceutical Sciences

Cover image for Vol. 102 Issue 5

May 2013

Volume 102, Issue 5

Pages 1383–1687

  1. Issue Information

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Review
    5. Commentary
    6. Global Health Commentary
    7. Pharmaceutical Biotechnology
    8. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    9. Pharmaceutical Nanotechnology
    10. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    11. Note
    1. Issue Information (pages i–ii)

      Article first published online: 15 APR 2013 | DOI: 10.1002/jps.23569

  2. Editorial

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Review
    5. Commentary
    6. Global Health Commentary
    7. Pharmaceutical Biotechnology
    8. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    9. Pharmaceutical Nanotechnology
    10. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    11. Note
    1. Editorial (pages 1383–1384)

      Ronald T. Borchardt

      Article first published online: 19 FEB 2013 | DOI: 10.1002/jps.23481

  3. Review

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Review
    5. Commentary
    6. Global Health Commentary
    7. Pharmaceutical Biotechnology
    8. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    9. Pharmaceutical Nanotechnology
    10. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    11. Note
    1. Towards better process understanding: Chemometrics and multivariate measurements in manufacturing of solid dosage forms (pages 1385–1403)

      Sanni Matero, Frans van Den Berg, Sami Poutiainen, Jukka Rantanen and Jari Pajander

      Article first published online: 19 FEB 2013 | DOI: 10.1002/jps.23472

  4. Commentary

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Review
    5. Commentary
    6. Global Health Commentary
    7. Pharmaceutical Biotechnology
    8. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    9. Pharmaceutical Nanotechnology
    10. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    11. Note
    1. The assessment of impurities for genotoxic potential and subsequent control in drug substance and drug product (pages 1404–1418)

      Linda K. Dow, Marvin M. Hansen, Brian W. Pack, Todd J. Page and Steven W. Baertschi

      Article first published online: 21 FEB 2013 | DOI: 10.1002/jps.23462

  5. Global Health Commentary

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Review
    5. Commentary
    6. Global Health Commentary
    7. Pharmaceutical Biotechnology
    8. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    9. Pharmaceutical Nanotechnology
    10. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    11. Note
  6. Pharmaceutical Biotechnology

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Review
    5. Commentary
    6. Global Health Commentary
    7. Pharmaceutical Biotechnology
    8. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    9. Pharmaceutical Nanotechnology
    10. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    11. Note
    1. How subvisible particles become invisible—relevance of the refractive index for protein particle analysis (pages 1434–1446)

      Sarah Zölls, Manuel Gregoritza, Ruedeeporn Tantipolphan, Michael Wiggenhorn, Gerhard Winter, Wolfgang Friess and Andrea Hawe

      Article first published online: 5 MAR 2013 | DOI: 10.1002/jps.23479

    2. Structural characterization of pharmaceutical heparins prepared from different animal tissues (pages 1447–1457)

      Li Fu, Guoyun Li, Bo Yang, Akihiro Onishi, Lingyun Li, Peilong Sun, Fuming Zhang and Robert J. Linhardt

      Article first published online: 21 MAR 2013 | DOI: 10.1002/jps.23501

  7. Pharmaceutics, Drug Delivery and Pharmaceutical Technology

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Review
    5. Commentary
    6. Global Health Commentary
    7. Pharmaceutical Biotechnology
    8. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    9. Pharmaceutical Nanotechnology
    10. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    11. Note
    1. Development of a codrug approach for sustained drug delivery across microneedle-treated skin (pages 1458–1467)

      Priyanka Ghosh, Raghotham R. Pinninti, Dana C. Hammell, Kalpana S. Paudel and Audra L. Stinchcomb

      Article first published online: 15 FEB 2013 | DOI: 10.1002/jps.23469

    2. Mesoporous silicate MCM-41 as a particulate carrier for octyl methoxycinnamate: Sunscreen release and photostability (pages 1468–1475)

      Valeria Ambrogi, Loredana Latterini, Fabio Marmottini, Cinzia Pagano and Maurizio Ricci

      Article first published online: 4 MAR 2013 | DOI: 10.1002/jps.23478

    3. Iontophoresis-targeted, follicular delivery of minoxidil sulfate for the treatment of alopecia (pages 1488–1494)

      Guilherme Martins Gelfuso, Tais Gratieri, M. Begoña Delgado-Charro, Richard H. Guy and Renata Fonseca Vianna Lopez

      Article first published online: 28 FEB 2013 | DOI: 10.1002/jps.23485

    4. Fundamental mechanisms for tablet dissolution: Simulation of particle deaggregation via brownian dynamics (pages 1569–1577)

      Erik Kaunisto, Anders Rasmuson, Johan Bergenholtz, Johan Remmelgas, Lennart Lindfors and Staffan Folestad

      Article first published online: 18 MAR 2013 | DOI: 10.1002/jps.23507

    5. New applications of phospholipid vesicle-based permeation assay: Permeation model mimicking skin barrier (pages 1588–1600)

      André Engesland, Merete Skar, Terkel Hansen, Nataša Škalko-basnet and Gøril Eide Flaten

      Article first published online: 25 MAR 2013 | DOI: 10.1002/jps.23509

  8. Pharmaceutical Nanotechnology

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Review
    5. Commentary
    6. Global Health Commentary
    7. Pharmaceutical Biotechnology
    8. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    9. Pharmaceutical Nanotechnology
    10. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    11. Note
    1. A novel self-assembly albumin nanocarrier for reducing doxorubicin-mediated cardiotoxicity (pages 1626–1635)

      Ahu Yuan, Jinhui Wu, Chenchen Song, Xiaolei Tang, Qian Qiao, Lili Zhao, Guangming Gong and Yiqiao Hu

      Article first published online: 19 FEB 2013 | DOI: 10.1002/jps.23455

  9. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Review
    5. Commentary
    6. Global Health Commentary
    7. Pharmaceutical Biotechnology
    8. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    9. Pharmaceutical Nanotechnology
    10. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    11. Note
    1. Interaction of miltefosine with the lipid and protein components of the erythrocyte membrane (pages 1661–1669)

      Rodrigo Alves Moreira, Sebastião Antonio Mendanha, Daiane Hansen and Antonio Alonso

      Article first published online: 1 MAR 2013 | DOI: 10.1002/jps.23496

  10. Note

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Review
    5. Commentary
    6. Global Health Commentary
    7. Pharmaceutical Biotechnology
    8. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    9. Pharmaceutical Nanotechnology
    10. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    11. Note
    1. Chlorothiazide is a substrate for the human uptake transporters OAT1 and OAT3 (pages 1683–1687)

      Viktória Juhász, Erzsébet Beéry, Zoltán Nagy, Annamária Bui, Éva Molnár, Joseph Krisjanis Zolnerciks, Rémi Magnan, Márton Jani and Peter Krajcsi

      Article first published online: 1 MAR 2013 | DOI: 10.1002/jps.23491

SEARCH

SEARCH BY CITATION